We are live on ! Find out more
PC

Parrish Capital Portfolio holdings

AUM $112M
This Fund
S&P 500
This Quarter Est. Return
+4.37%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$112M
AUM Growth
+$1.79M
Cap. Flow
+$669K
Cap. Flow %
0.6%
Top 10 Hldgs %
25.22%
Holding
87
New
1
Increased
50
Reduced
30
Closed
1

Top Buys

Rank Stock Value
1
CSCO icon
Cisco
CSCO
+$362K
2
WHR icon
Whirlpool
WHR
+$216K
3
EL icon
Estee Lauder
EL
+$162K
4
MRVL icon
Marvell Technology
MRVL
+$135K
5
AB icon
AllianceBernstein
AB
+$130K

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$534K
2
ETN icon
Eaton
ETN
+$310K
3
AZN icon
AstraZeneca
AZN
+$246K
4
AAPL icon
Apple
AAPL
+$232K
5
TRV icon
Travelers Companies
TRV
+$218K

Sector Composition

Rank Sector Weight
1 Financials 17.92%
2 Technology 14.39%
3 Healthcare 12.62%
4 Communication Services 12.36%
5 Industrials 10.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GOOGL icon
1
Alphabet (Google) Class A
GOOGL
$4.36T
$4.08M 3.63%
14,173
-343
-2% -$108K
AAPL icon
2
Apple
AAPL
$4.54T
$4.04M 3.6%
15,922
-891
-5% -$232K
GILD icon
3
Gilead Sciences
GILD
$162B
$3.17M 2.83%
22,746
-1,149
-5% -$161K
TEVA icon
4
Teva Pharmaceuticals
TEVA
$40.8B
$2.93M 2.61%
97,153
-16,584
-15% -$534K
XOM icon
5
ExxonMobil
XOM
$644B
$2.57M 2.29%
15,132
-153
-1% -$22.3K
ORCL icon
6
Oracle
ORCL
$374B
$2.51M 2.24%
17,096
+629
+4% +$102K
GE icon
7
GE Aerospace
GE
$374B
$2.39M 2.13%
8,416
-610
-7% -$192K
AZN icon
8
AstraZeneca
AZN
$263B
$2.28M 2.03%
11,555
-1,278
-10% -$246K
VOD icon
9
Vodafone
VOD
$36.3B
$2.18M 1.94%
145,198
-6,652
-4% -$97.2K
VZ icon
10
Verizon
VZ
$195B
$2.16M 1.92%
42,941
-434
-1% -$20.1K
TTE icon
11
TotalEnergies
TTE
$195B
$2.13M 1.9%
23,450
+834
+4% +$63.7K
SHEL icon
12
Shell
SHEL
$254B
$2.06M 1.84%
22,184
+631
+3% +$51K
META icon
13
Meta Platforms (Facebook)
META
$1.42T
$1.96M 1.74%
3,418
+61
+2% +$39.1K
AB icon
14
AllianceBernstein
AB
$3.43B
$1.95M 1.74%
52,152
+3,304
+7% +$130K
ETN icon
15
Eaton
ETN
$161B
$1.9M 1.69%
5,300
-870
-14% -$310K
GS icon
16
Goldman Sachs
GS
$300B
$1.83M 1.63%
2,166
-122
-5% -$109K
QCOM icon
17
Qualcomm
QCOM
$155B
$1.8M 1.6%
13,943
+736
+6% +$107K
LHX icon
18
L3Harris
LHX
$51.6B
$1.79M 1.6%
5,186
-47
-0.9% -$16.4K
ALB icon
19
Albemarle
ALB
$13.9B
$1.76M 1.57%
9,786
-812
-8% -$139K
SO icon
20
Southern Company
SO
$109B
$1.72M 1.53%
17,828
-221
-1% -$20.4K
ABBV icon
21
AbbVie
ABBV
$443B
$1.71M 1.52%
7,862
-422
-5% -$93.6K
GEV icon
22
GE Vernova
GEV
$264B
$1.69M 1.51%
1,939
-123
-6% -$96K
PANW icon
23
Palo Alto Networks
PANW
$270B
$1.68M 1.5%
10,485
+331
+3% +$55.6K
CBOE icon
24
Cboe Global Markets
CBOE
$32.5B
$1.66M 1.48%
5,892
-363
-6% -$101K
GSK icon
25
GSK
GSK
$104B
$1.63M 1.46%
29,588
-639
-2% -$34.6K
1
2 3 4

Similar funds

DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
APFP
Action Point Financial Planning Grand Rapids, Michigan $112M AUM
GW
Graetz Wealth Jenison, Michigan $112M AUM
PFS
Professional Financial Solutions Falls Chruch, Virginia $112M AUM
VCM
Veradace Capital Management Dallas, Texas $112M AUM
AIP
Arrowpoint Investment Partners Singapore $113M AUM 73.91% 1-Year Est. Return
MWP
Momentum Wealth Planning Estero, Florida $113M AUM 26.08% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return

Parrish Capital's Q1 2026 Portfolio in Review

As of Q1 2026, Parrish Capital held 87 positions worth $112M, up 1.6% from $110M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Trading was light in Q1 2026: portfolio turnover was 2.3%. Parrish Capital opened 1 new position and exited 1, leaving the 87-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 20% a quarter earlier, followed by Technology and Healthcare.

  • Parrish Capital's largest Q1 2026 buy was Cisco: 4,626 shares worth $359K.
  • Parrish Capital added most to Whirlpool in Q1 2026, an estimated $216K increase.
  • Parrish Capital's biggest Q1 2026 reduction was Teva Pharmaceuticals, cutting an estimated $534K.
  • Parrish Capital fully exited Visa in Q1 2026, selling an estimated $205K.
  • Parrish Capital's ten largest holdings make up 25% of its $112M portfolio in Q1 2026.
  • Parrish Capital opened 1 new position and closed 1 in Q1 2026.
  • Parrish Capital's portfolio value rose 1.6% quarter-over-quarter to $112M.

Based on Parrish Capital's 13F filing for Q1 2026, filed 28 Apr 2026.